Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
26.02
+0.08 (0.31%)
At close: Jun 11, 2025, 2:57 PM CST
Liaoning Chengda Biotechnology Company Description
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China.
It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines.
The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries.
Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.
Liaoning Chengda Biotechnology Co.,Ltd.
Country | China |
Founded | 2002 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 1,732 |
CEO | Yu Mao |
Contact Details
Address: No. 1 Xinfang Street Shenyang, 110179 China | |
Phone | 86 24 8378 2632 |
Website | cdbio.cn |
Stock Details
Ticker Symbol | 688739 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Yu Mao | GM and Director |
Jianwei Cui | Deputy GM, Chief Financial Officer, Secretary, Accounting Supervisor and Director |
Weiqiang Sun | Deputy GM and Chief Scientist |
Junwei Yang | Deputy GM and Director |
Xin Chen | Deputy General Manager |
Deming Yuan | Deputy General Manager |
Huanyu Wang | Deputy General Manager |